Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 205003

Expand all

PRESTALIA (AMLODIPINE BESYLATE; PERINDOPRIL ARGININE)
EQ 2.5MG BASE;3.5MG Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; PERINDOPRIL ARGININE
Proprietary Name: PRESTALIA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE;3.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N205003
Product Number: 001
Approval Date: Jan 21, 2015
Applicant Holder Full Name: MARINA BIOTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information

PRESTALIA (AMLODIPINE BESYLATE; PERINDOPRIL ARGININE)
EQ 5MG BASE;7MG Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; PERINDOPRIL ARGININE
Proprietary Name: PRESTALIA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE;7MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N205003
Product Number: 002
Approval Date: Jan 21, 2015
Applicant Holder Full Name: MARINA BIOTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information

PRESTALIA (AMLODIPINE BESYLATE; PERINDOPRIL ARGININE)
EQ 10MG BASE;14MG Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; PERINDOPRIL ARGININE
Proprietary Name: PRESTALIA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE;14MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N205003
Product Number: 003
Approval Date: Jan 21, 2015
Applicant Holder Full Name: MARINA BIOTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English